| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.5 |